Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» U300
U300
Makings of a Wide Moat in Diabetes Care
Morningstar
Fri, 03/28/14 - 11:16 am
diabetes
Takeda
Sanofi
GSK
Victoza
Merck
insulin
Novo Nordisk
Afrezza
U300
Tresiba
Eli Lilly
Sanofi Announces New Phase 3 Results for Investigational New Insulin U300
Yahoo
Tue, 12/3/13 - 09:33 am
Sanofi
insulin
diabetes
U300
The Future of Sanofi's Insulin Empire
Motley Fool
Fri, 07/19/13 - 10:17 am
Sanofi
insulin
Eli Lilly
Novo Nordisk
diabetes
U300
Lantus
LixiLan
Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
Yahoo/Market Wired
Sun, 06/23/13 - 11:30 am
Sanofi
U300
insulin
type 2 diabetes
diabetes